European Science Editing 46: e54172, doi: 10.3897/ese.2020.e54172
Building transparency and trust in industry-sponsored clinical research through open access publishing
Barbara DeCastro‡, Anna Geraci§, Jayme Trott|, G. Peter Snyder¶, Yaswant Dayaram#‡ GlaxoSmithKline, Collegeville, United States of America§ International Society for Medical Publication Professionals, Tarrytown, United States of America| Janssen Global Services, LLC, Raritan, United States of America¶ AstraZeneca, Gaithersburg, United States of America# Bayer HealthCare Pharmaceuticals, Whippany, United States of America
Corresponding author: Barbara DeCastro ( barbara.b.decastro@gsk.com; allison.vetter@hcg-int.com ) Academic editor: Joan Marsh © Barbara DeCastro, Anna Geraci, Jayme Trott, G. Peter Snyder, Yaswant Dayaram. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Citation:
DeCastro B, Geraci A, Trott J, Snyder GP, Dayaram Y (2020) Building trust and transparency of industry-sponsored clinical research through open access publishing. European Science Editing 46: e54172. https://doi.org/10.3897/ese.2020.e54172 |  |
Abstract
A desire for both transparency in research and widespread access to the results of research has led to activism in support of open access publishing. Open access publishing, particularly publishing industry-sponsored research, can be complex. The overarching benefits of, and challenges to, open access are described, illustrated with the initiatives related to Medical Publishing Insights and Practices to help promote a better understanding of open access and its importance in ensuring transparency in industry-sponsored research.
Keywords
Industry-sponsored research, MPIP, Open Access, Transparency